Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
20.10
+0.81 (4.20%)
At close: Sep 1, 2026, 4:00 PM EDT
19.86
-0.24 (-1.19%)
Pre-market: Sep 2, 2026, 8:36 AM EDT
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $1.79 billion as of September 2, 2026. Its market cap has increased by 27.59% in one year.
Market Cap
1.79B
Enterprise Value
1.83B
1-Year Change
27.59%
Ranking
Category
Stock Price
$20.10
ChartMarket Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $1.79B, an increase of 760.44%. That is a compound annual growth rate of 22.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 1.79B | -1.71% |
| Dec 31, 2025 | 1.83B | 61.83% |
| Dec 31, 2024 | 1.13B | -25.02% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
| Mar 3, 2016 | 208.60M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vir Biotechnology | 1.83B |
| Inhibrx Biosciences | 1.82B |
| Septerna | 1.82B |
| Intellia Therapeutics | 1.80B |
| Recursion Pharmaceuticals | 1.79B |
| Damora Therapeutics | 1.79B |
| Fortrea Holdings | 1.79B |
| Braveheart Bio | 1.76B |